Cartesian Therapeutics (RNAC) Times Interest Earned (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly Times Interest Earned came in at -$22.67 in Q1 2026, up 67.17% year-on-year from -$13.56 in Q1 2025, and down 161.31% on a QoQ basis from $36.97 in Q4 2025.
Cartesian Therapeutics (RNAC) Times Interest Earned (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Times Interest Earned data on file, last reported at -$22.67 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 67.17% year-over-year to -$22.67 in Q1 2026; TTM through Mar 2026 was -$400.04, a 101410.73% decrease from a year earlier, with the FY2025 full-year figure at -$0.48, down 172.72% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$22.67, down from $36.97 in the prior quarter.
- Over the last five years, Times Interest Earned for RNAC reached as high as $36.97 in Q4 2025 and fell as low as -$69.05 in Q1 2025.
- Historically, Times Interest Earned has averaged -$7.05 across 5 years, with a median of -$1.99 in 2022.
- Across the five-year window, Times Interest Earned surged 2949.22% in 2022 and tumbled 9394.14% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$6.0 in 2022, then surged by 95.36% to -$0.28 in 2023, then tumbled by 9394.14% to -$26.44 in 2024, then surged by 239.83% to $36.97 in 2025, then slumped by 161.31% to -$22.67 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$22.67 in Q1 2026, $36.97 in Q4 2025, and -$4.14 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Cartesian Therapeutics | 210.28 Mn | 210.28 Mn | - | -22.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.67 |
| Dec 31, 2025 | 36.97 |
| Sep 30, 2025 | -4.14 |
| Jun 30, 2025 | -1.28 |
| Mar 31, 2025 | -69.05 |
| Dec 31, 2024 | -26.44 |
| Sep 30, 2024 | -1.16 |
| Jun 30, 2024 | 0.42 |
| Mar 31, 2024 | -1.05 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | -10.26 |
| Jun 30, 2023 | -24.78 |
| Mar 31, 2023 | -22.75 |
| Dec 31, 2022 | -6.00 |
| Sep 30, 2022 | -1.99 |
| Jun 30, 2022 | 19.38 |
| Mar 31, 2022 | 15.24 |
| Dec 31, 2021 | 8.17 |
| Sep 30, 2021 | -2.77 |
| Jun 30, 2021 | 0.64 |